AI assistant
NEPHROS INC — Director's Dealing 2012
Mar 15, 2012
34594_dirs_2012-03-15_561f0ea3-c62e-47d6-b807-4bf7424a39e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEPHROS INC (NEPH.OB)
CIK: 0001196298
Period of Report: 2012-02-16
Reporting Person: Mieyal Paul A (Director, Acting Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-16 | Non-qualified stock option (right to buy) | $0.83 | A | 10000 | Acquired | 2022-02-16 | Common Stock (10000) | Direct |
Footnotes
F1: On February 16, 2012, the Company granted an option to purchase 10,000 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2004 Stock Incentive Plan. At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vested immediately with respect to 3,334 shares on February 16, 2012. The remainder of the Option vests in an installment of 3,333 shares on each of the first and second anniversary of the grant date.